Status:
COMPLETED
Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials
Lead Sponsor:
Istanbul Bakirkoy Maternity and Children Diseases Hospital
Conditions:
Pelvic Inflammatory Disease
Eligibility:
FEMALE
14-45 years
Phase:
PHASE4
Brief Summary
We aimed to compare efficacy and safety of combination therapy with oral ofloxacin, 400 mg twice daily, plus oral metronidazole, 500 mg twice daily, for 14 days, with moxifloxacin monotherapy, 400 mg ...
Eligibility Criteria
Inclusion
- Women diagnosed uncomplicated PID
- Patients age are between 14 with 45
- Pelvic tenderness and vaginal discharge
Exclusion
- Urinary Tract Enfections
- Tubo-ovarian abscess and complicated PID
- Hıstory of antibiotics treatment
- Other pelvic pain causes
- Endometriosis
- Delivery,abortion and surgery within last months
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
1303 Patients enrolled
Trial Details
Trial ID
NCT01799356
Start Date
June 1 2010
End Date
March 1 2013
Last Update
August 28 2013
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
T.C.S.B. İstanbul Training Research Hospital
Samatya, Fatih, Turkey (Türkiye), 34180
2
T.C.S.B. Kanuni Sultan Suleyman Training Hospital
Istanbul, Kucukcekmece, Turkey (Türkiye), 34280
3
T.C.S.B Mardin Women and Children Hospital
Mardin, Mardin, Turkey (Türkiye), 47000
4
T.C.S.B. Şişli Etfal Training Research Hospital
Şişli, Şişli, Turkey (Türkiye), 34150